PTC Therapeutics, Inc. is a company in the U.S. stock market and it is a holding in 47 U.S.-traded ETFs. PTCT has around 4.4M shares in the U.S. ETF market. The largest ETF holder of PTCT is the SPDR S&P Biotech ETF (XBI), with approximately 1.03M shares. Investors may also find of interest that the ETF with the largest allocation to PTCT stock is Global X Genomics & Biotechnology ETF (GNOM), with a portfolio weight of 5.52%. On average, U.S. ETFs allocate 0.56% of PTCT to their portfolios.
Additionally, PTCT is a favorite stock for Vanilla and Multi-factor ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with PTCT as a holding is the ProShares Ultra NASDAQ Biotechnology (BIB), with a return of 21.51%.